Reuters logo
7 months ago
BRIEF-Leap Therapeutics presents Biomarker and efficacy data
February 3, 2017 / 1:21 PM / 7 months ago

BRIEF-Leap Therapeutics presents Biomarker and efficacy data

Feb 3 (Reuters) - Leap Therapeutics Inc :

* Leap Therapeutics presents biomarker and efficacy data at the cholangiocarcinoma foundation 2017 annual meeting

* Leap Therapeutics -data showed DKN-01 monoclonal antibody resulted in statistically significant changes in inflammatory and anti-angiogenic biomarkers Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below